There was no significant difference in serum FSIP1 levels before and after surgery in the 122 patients with primary breast cancer (4, 637 ± 3, 276 pg/ml vs. 4, 713 ± 3, 065 pg/ml, p = 0.162; Figure 2). Here, FSIP1 is linked to breast cancer.